Your browser doesn't support javascript.
loading
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide.
Trivedi, Ashifa; Sharma, Sadhna; Govindan, Ranjith.
Affiliation
  • Trivedi A; Pharmacy Department, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, Greater London, UK ashifa.trivedi@nhs.net.
  • Sharma S; Pharmacy Department, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, Greater London, UK.
  • Govindan R; Paediatrics, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, Greater London, UK.
Eur J Hosp Pharm ; 29(4): 231-234, 2022 07.
Article in En | MEDLINE | ID: mdl-33106284
ABSTRACT
We describe the case of an 11-year-old male patient who presented with a new onset of rash after a recent introduction of zonisamide. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome) is a very serious but rare adverse effect of anticonvulsants such as carbamazepine and phenytoin; however, the reported incidence on zonisamide is scant. DRESS syndrome is complex in its presentation. This patient presented with rash, fever, lymphadenopathy, severe skin erythema, oedema and reduced Glasgow Coma Scale (GCS). He was successfully treated with pulsed intravenous methylprednisolone and intravenous immunoglobulin. The patient was discharged home well after a 3-week admission.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilia / Exanthema / Drug Hypersensitivity Syndrome Type of study: Diagnostic_studies / Etiology_studies Limits: Child / Humans / Male Language: En Journal: Eur J Hosp Pharm Year: 2022 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilia / Exanthema / Drug Hypersensitivity Syndrome Type of study: Diagnostic_studies / Etiology_studies Limits: Child / Humans / Male Language: En Journal: Eur J Hosp Pharm Year: 2022 Type: Article Affiliation country: United kingdom